Literature DB >> 19960018

The effect of salt on renal damage in eNOS-deficient mice.

Geraldine Daumerie1, Lakeesha Bridges, Sadiqa Yancey, Wendell Davis, Paul Huang, Joseph Loscalzo, Mildred A Pointer.   

Abstract

African Americans have an increased incidence of end-stage renal disease and are characterized as having reduced bioavailability of nitric oxide and salt-sensitivity. We propose that endothelial nitric oxide synthase (eNOS) knockout mice (eNOS(-/-)) are a suitable model of hypertension-associated renal injury as seen in African Americans. Therefore, the purpose of this study was to determine whether older eNOS(-/-) mice have hypertension-associated renal injury and if dietary salt modulates this injury. Six-month-old eNOS(-/-) mice were placed on 0.12%, 0.45% or 8% NaCl diet for 8 weeks and blood pressure measured weekly; kidneys were collected for pathology evaluation and scoring at the end of the 8-week period. Mice deficient of eNOS were hypertensive at baseline compared with control mice in all three groups (128+/-3 vs. 112+/-3, P<0.05). Blood pressure was significantly elevated from baseline in eNOS(-/-) on 0.45 and 8% salt diets (P<0.02). The composite renal pathology scores for eNOS(-/-) mice were significantly greater than wild-type mice, indicating high salt intake exacerbates the injury (P<0.001 vs. normal salt diet). eNOS(-/-) mice may be used as a model of salt-induced and hypertension-associated renal injury as seen in African Americans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960018      PMCID: PMC4419703          DOI: 10.1038/hr.2009.197

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  32 in total

1.  Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.

Authors:  X P Yang; Y H Liu; E G Shesely; M Bulagannawar; F Liu; O A Carretero
Journal:  Hypertension       Date:  1999-07       Impact factor: 10.190

2.  Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury.

Authors:  Clarice K Fujihara; Claudia R Sena; Denise M A C Malheiros; Ana L Mattar; Roberto Zatz
Journal:  Am J Physiol Renal Physiol       Date:  2005-10-04

3.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

4.  Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice.

Authors:  Allison M Leonard; Linda L Chafe; Jean-Pierre Montani; Bruce N Van Vliet
Journal:  Am J Hypertens       Date:  2006-12       Impact factor: 2.689

5.  High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure.

Authors:  Vito M Campese; Pantea Mozayeni; Shaohua Ye; Michael Gumbard
Journal:  J Nephrol       Date:  2002 Jul-Aug       Impact factor: 3.902

6.  Definitions and characteristics of sodium sensitivity and blood pressure resistance.

Authors:  M H Weinberger; J Z Miller; F C Luft; C E Grim; N S Fineberg
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

7.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.

Authors:  Yukiko Kanetsuna; Keiko Takahashi; Michio Nagata; Maureen A Gannon; Matthew D Breyer; Raymond C Harris; Takamune Takahashi
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

8.  Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats.

Authors:  E D Frohlich; Y Chien; S Sesoko; B L Pegram
Journal:  Am J Physiol       Date:  1993-01

9.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

Authors:  N B Shulman; C E Ford; W D Hall; M D Blaufox; D Simon; H G Langford; K A Schneider
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

10.  Dietary sodium intake and left ventricular hypertrophy in normotensive rats.

Authors:  B X Yuan; F H Leenen
Journal:  Am J Physiol       Date:  1991-11
View more
  6 in total

1.  Nitric oxide production by glomerular podocytes.

Authors:  Oleg Palygin; Daria V Ilatovskaya; Vladislav Levchenko; Bradley T Endres; Aron M Geurts; Alexander Staruschenko
Journal:  Nitric Oxide       Date:  2017-11-08       Impact factor: 4.427

2.  Physiological stress increases renal injury in eNOS-knockout mice.

Authors:  Mildred A Pointer; Geraldine Daumerie; LaKessha Bridges; Sadiqa Yancey; Kelly Howard; Wendell Davis; Paul Huang; Joseph Loscalzo
Journal:  Hypertens Res       Date:  2011-12-15       Impact factor: 3.872

3.  Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.

Authors:  Qiumei Chen; Richard E Sievers; Monika Varga; Sourabh Kharait; Daniel J Haddad; Aaron K Patton; Christopher S Delany; Sarah C Mutka; Joan P Blonder; Gregory P Dubé; Gary J Rosenthal; Matthew L Springer
Journal:  J Appl Physiol (1985)       Date:  2013-01-24

4.  Gender differences in preclinical markers of kidney injury in a rural north Carolina african-american cohort.

Authors:  Mildred A Pointer; Kianda Hicks; ClarLynda Williams-Devane; Candace Wells; Natasha Greene
Journal:  Front Public Health       Date:  2015-01-26

5.  High-salt intake reduces renal tissue levels of inflammatory cytokines in mice.

Authors:  Purnima Singh; Roxan Stephenson; Alexander Castillo; Dewan S A Majid
Journal:  Physiol Rep       Date:  2021-01

6.  Nephron-Specific Disruption of Nitric Oxide Synthase 3 Causes Hypertension and Impaired Salt Excretion.

Authors:  Yang Gao; Deborah Stuart; Takamune Takahishi; Donald E Kohan
Journal:  J Am Heart Assoc       Date:  2018-07-11       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.